|Author (Person)||Blomqvist, Soile, Broas, Markku, Haveri, Anu, Hepojoki, Jussi, Ikonen, Niina, Jiang, Miao, Kallio-Kokko, Hannimari, Kantele, Anu, Kuivanen, Suvi, Lappalainen, Maija, Mannonen, Laura, Melin, Merit, Österlund, Pamela, Pitkäpaasi, Marjaana, Puumalainen, Taneli, Rönkkö, Esa, Salminen, Mika, Sane, Jussi, Savolainen-Kopra, Carita, Siira, Lotta, Smura, Teemu, Strandin, Tomas, Vapalahti, Olli|
|Publisher||European Centre for Disease Prevention and Control (ECDC)|
|Series Details||Volume 25, Number 11|
|Publication Date||March 2020|
|Content Type||Journal Article|
The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms.
The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins.
|Subject Tags||Diseases, Public Health|
|Countries / Regions||Finland|